Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(ADP-ribose) polymerase family member 10 (PARP10) is a human enzyme encoded by the PARP10 (ARTD10) gene and is part of the poly(ADP-ribose) polymerase family, a group of enzymes involved in DNA repair, genomic stability, and the regulation of chromatin structure and gene transcription[3][7]. Specifically, PARP10 functions as a mono-ADP-ribosyltransferase, mediating the transfer of a single ADP-ribose moiety to target proteins such as histones, thereby modulating transcriptional activity and chromatin organization[9]. While clinical therapeutics have focused on other PARPs (such as PARP1/2) in cancer, PARP10 is increasingly studied for its role in gene regulation and potential oncogenic pathways[4][7]. Several PARP inhibitors (e.g., veliparib, 3-aminobenzamide) have been used in structural and functional studies of PARP10, but selective inhibition and disease-specific targeting of PARP10 remains under investigation[4].
Inhibition of enzyme catalytic activity (by small molecule PARP inhibitors)[4]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(ADP-ribose) polymerase family member 10 (PARP10).